Br. Heart J. -- Table of Contents (72 [3 Suppl])

Home

Only Table of Contents and PDFs available for this issue

September 1994 (Volume 72, 3 Suppl) [Index by author]

		Foreword Basic Science Coronary Artery Disease Hypertension Myocardial Infarction Ventricular Dysfunction and Heart Failure


Find articles in this issue containing these words: [Search ALL Issues]

Table of Contents (PDF) | Cover (PDF) | Administration (PDF)

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstracts' button. To see one abstract at a time, click its [Abstract] link.

Foreword

ACE inhibitors: current understanding and future directions
John G F Cleland
Br. Heart J. 1994; 72 (3 Suppl): S1. doi:10.1136/hrt.72.3_Suppl.S1 [PDF] [Request Permissions]

Basic Science

Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies
Kevin Morgan
Br. Heart J. 1994; 72 (3 Suppl): S3-S10. doi:10.1136/hrt.72.3_Suppl.S3 [PDF] [Request Permissions]

Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition
Helmut Drexler
Br. Heart J. 1994; 72 (3 Suppl): S11-S14. doi:10.1136/hrt.72.3_Suppl.S11 [PDF] [Request Permissions]

Coronary Artery Disease

Effects of ACE inhibitors on coronary haemodynamics and angina pectoris
M K Davies
Br. Heart J. 1994; 72 (3 Suppl): S52-S56. doi:10.1136/hrt.72.3_Suppl.S52 [PDF] [Request Permissions]

Effects of ACE inhibitors on coronary atherosclerosis and restenosis
Adam D Timmis and Bertram Pitt
Br. Heart J. 1994; 72 (3 Suppl): S57-S60. doi:10.1136/hrt.72.3_Suppl.S57 [PDF] [Request Permissions]

Hypertension

Role of ACE inhibitors in uncomplicated essential hypertension
J I S Robertson
Br. Heart J. 1994; 72 (3 Suppl): S15-S23. doi:10.1136/hrt.72.3_Suppl.S15 [PDF] [Request Permissions]

Role of ACE inhibitors in hypertension with left ventricular hypertrophy
A Mark Richards, M Gary Nicholls, and Ian G Crozier
Br. Heart J. 1994; 72 (3 Suppl): S24-S32. doi:10.1136/hrt.72.3_Suppl.S24 [PDF] [Request Permissions]

Role of ACE inhibitors in hypertension complicated by vascular disease
Gordon T McInnes
Br. Heart J. 1994; 72 (3 Suppl): S33-S37. doi:10.1136/hrt.72.3_Suppl.S33 [PDF] [Request Permissions]

Renoprotective role of ACE inhibitors in diabetic nephropathy
Carl Erik Mogensen
Br. Heart J. 1994; 72 (3 Suppl): S38-S45. doi:10.1136/hrt.72.3_Suppl.S38 [PDF] [Request Permissions]

ACE inhibitors in non-diabetic renal disease
Richard J Fluck and Anthony E G Raine
Br. Heart J. 1994; 72 (3 Suppl): S46-S51. doi:10.1136/hrt.72.3_Suppl.S46 [PDF] [Request Permissions]

Myocardial Infarction

Insights from animal models of myocardial infarction: do ACE inhibitors limit the structural response?
Jos F M Smits and Mat J A P Daemen
Br. Heart J. 1994; 72 (3 Suppl): S61-S64. doi:10.1136/hrt.72.3_Suppl.S61 [PDF] [Request Permissions]

Neuroendocrine activation after myocardial infarction
Jouko Remes
Br. Heart J. 1994; 72 (3 Suppl): S65-S69. doi:10.1136/hrt.72.3_Suppl.S65 [PDF] [Request Permissions]

What to expect from ACE inhibitors after myocardial infarction
S G Ball and A S Hall
Br. Heart J. 1994; 72 (3 Suppl): S70-S74. doi:10.1136/hrt.72.3_Suppl.S70 [PDF] [Request Permissions]

Ventricular Dysfunction and Heart Failure

Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?
Axel Sigurdsson and Karl Swedberg
Br. Heart J. 1994; 72 (3 Suppl): S75-S80. doi:10.1136/hrt.72.3_Suppl.S75 [PDF] [Request Permissions]

How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?
John G F Cleland and Sundeep Puri
Br. Heart J. 1994; 72 (3 Suppl): S81-S86. doi:10.1136/hrt.72.3_Suppl.S81 [PDF] [Request Permissions]

How do changes in lifestyle complement medical treatment in heart failure?
J Soler-Soler and G Permanyer-Miralda
Br. Heart J. 1994; 72 (3 Suppl): S87-S91. doi:10.1136/hrt.72.3_Suppl.S87 [PDF] [Request Permissions]

Inotropic agents for heart failure: what if digoxin increases mortality?
W J Remme
Br. Heart J. 1994; 72 (3 Suppl): S92-S99. doi:10.1136/hrt.72.3_Suppl.S92 [PDF] [Request Permissions]

Medical treatment beyond ACE inhibition: false promise or lack of vision?
J T Walsh and A J Cowley
Br. Heart J. 1994; 72 (3 Suppl): S100-S105. doi:10.1136/hrt.72.3_Suppl.S100 [PDF] [Request Permissions]

ACE inhibitors for heart failure: a question of dose
John G F Cleland and Philip A Poole-Wilson
Br. Heart J. 1994; 72 (3 Suppl): S106-S110. doi:10.1136/hrt.72.3_Suppl.S106 [PDF] [Request Permissions]

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

	ACE inhibitors: current understanding and future directions John G F Cleland Br. Heart J. 1994; 72 (3 Suppl): S1. doi:10.1136/hrt.72.3_Suppl.S1 [PDF] [Request Permissions]

	Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies Kevin Morgan Br. Heart J. 1994; 72 (3 Suppl): S3-S10. doi:10.1136/hrt.72.3_Suppl.S3 [PDF] [Request Permissions]

	Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition Helmut Drexler Br. Heart J. 1994; 72 (3 Suppl): S11-S14. doi:10.1136/hrt.72.3_Suppl.S11 [PDF] [Request Permissions]

	Effects of ACE inhibitors on coronary haemodynamics and angina pectoris M K Davies Br. Heart J. 1994; 72 (3 Suppl): S52-S56. doi:10.1136/hrt.72.3_Suppl.S52 [PDF] [Request Permissions]

	Effects of ACE inhibitors on coronary atherosclerosis and restenosis Adam D Timmis and Bertram Pitt Br. Heart J. 1994; 72 (3 Suppl): S57-S60. doi:10.1136/hrt.72.3_Suppl.S57 [PDF] [Request Permissions]

	Role of ACE inhibitors in uncomplicated essential hypertension J I S Robertson Br. Heart J. 1994; 72 (3 Suppl): S15-S23. doi:10.1136/hrt.72.3_Suppl.S15 [PDF] [Request Permissions]

	Role of ACE inhibitors in hypertension with left ventricular hypertrophy A Mark Richards, M Gary Nicholls, and Ian G Crozier Br. Heart J. 1994; 72 (3 Suppl): S24-S32. doi:10.1136/hrt.72.3_Suppl.S24 [PDF] [Request Permissions]

	Role of ACE inhibitors in hypertension complicated by vascular disease Gordon T McInnes Br. Heart J. 1994; 72 (3 Suppl): S33-S37. doi:10.1136/hrt.72.3_Suppl.S33 [PDF] [Request Permissions]

	Renoprotective role of ACE inhibitors in diabetic nephropathy Carl Erik Mogensen Br. Heart J. 1994; 72 (3 Suppl): S38-S45. doi:10.1136/hrt.72.3_Suppl.S38 [PDF] [Request Permissions]

	ACE inhibitors in non-diabetic renal disease Richard J Fluck and Anthony E G Raine Br. Heart J. 1994; 72 (3 Suppl): S46-S51. doi:10.1136/hrt.72.3_Suppl.S46 [PDF] [Request Permissions]

	Insights from animal models of myocardial infarction: do ACE inhibitors limit the structural response? Jos F M Smits and Mat J A P Daemen Br. Heart J. 1994; 72 (3 Suppl): S61-S64. doi:10.1136/hrt.72.3_Suppl.S61 [PDF] [Request Permissions]

	Neuroendocrine activation after myocardial infarction Jouko Remes Br. Heart J. 1994; 72 (3 Suppl): S65-S69. doi:10.1136/hrt.72.3_Suppl.S65 [PDF] [Request Permissions]

	What to expect from ACE inhibitors after myocardial infarction S G Ball and A S Hall Br. Heart J. 1994; 72 (3 Suppl): S70-S74. doi:10.1136/hrt.72.3_Suppl.S70 [PDF] [Request Permissions]

	Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure? Axel Sigurdsson and Karl Swedberg Br. Heart J. 1994; 72 (3 Suppl): S75-S80. doi:10.1136/hrt.72.3_Suppl.S75 [PDF] [Request Permissions]

	How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death? John G F Cleland and Sundeep Puri Br. Heart J. 1994; 72 (3 Suppl): S81-S86. doi:10.1136/hrt.72.3_Suppl.S81 [PDF] [Request Permissions]

	How do changes in lifestyle complement medical treatment in heart failure? J Soler-Soler and G Permanyer-Miralda Br. Heart J. 1994; 72 (3 Suppl): S87-S91. doi:10.1136/hrt.72.3_Suppl.S87 [PDF] [Request Permissions]

	Inotropic agents for heart failure: what if digoxin increases mortality? W J Remme Br. Heart J. 1994; 72 (3 Suppl): S92-S99. doi:10.1136/hrt.72.3_Suppl.S92 [PDF] [Request Permissions]

	Medical treatment beyond ACE inhibition: false promise or lack of vision? J T Walsh and A J Cowley Br. Heart J. 1994; 72 (3 Suppl): S100-S105. doi:10.1136/hrt.72.3_Suppl.S100 [PDF] [Request Permissions]

	ACE inhibitors for heart failure: a question of dose John G F Cleland and Philip A Poole-Wilson Br. Heart J. 1994; 72 (3 Suppl): S106-S110. doi:10.1136/hrt.72.3_Suppl.S106 [PDF] [Request Permissions]

Register for free content

Cardiology Jobs